Compare HROW & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | LZB |
|---|---|---|
| Founded | 1998 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2008 | 1994 |
| Metric | HROW | LZB |
|---|---|---|
| Price | $28.30 | $32.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $62.63 | $41.00 |
| AVG Volume (30 Days) | ★ 635.5K | 492.0K |
| Earning Date | 11-09-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 2.94% |
| EPS Growth | ★ 71.43 | 5.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,349,433,000.00 |
| Revenue This Year | $28.13 | N/A |
| Revenue Next Year | $56.02 | $3.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.76 | $28.39 |
| 52 Week High | $54.98 | $44.90 |
| Indicator | HROW | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 59.02 |
| Support Level | $27.75 | $31.33 |
| Resistance Level | $30.28 | $34.09 |
| Average True Range (ATR) | 1.66 | 0.86 |
| MACD | 0.31 | 0.28 |
| Stochastic Oscillator | 35.42 | 70.96 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.